Aardvark Therapeutics Inc. Common Stock
AARD | NASDAQ
$5.67
+$0.10 (+1.80%)
Sep 22, 2026, 11:34 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -73.96M | -74.72M | -62.73M | -53.47M | -40.86M | -31.08M | -22.79M | -15.57M | -12.2M | -6.12M | -3.95M | -1.72M |
Interest Income | 4.06M | 4.85M | 5.14M | 4.73M | 4.38M | 3.49M | 2.41M | 1.82M | 950K | 356K | 253K | 135K |
Pretax Income | -69.89M | -69.87M | -57.59M | -48.77M | -36.64M | -27.72M | -20.59M | -13.85M | -11.78M | -6.33M | -4.15M | -2.11M |
Net Income | -69.89M | -69.87M | -57.59M | -48.77M | -36.64M | -27.72M | -20.59M | -13.85M | -11.78M | -6.33M | -4.15M | -2.11M |
Selling & General & Admin | 18.9M | 16.97M | 13.79M | 10.77M | 7.83M | 7.16M | 5.31M | 4.44M | 3.95M | 1.92M | 1.06M | 538K |
Research & Development | 55.06M | 57.75M | 48.94M | 42.7M | 33.03M | 23.91M | 17.36M | 10.84M | 7.74M | 3.71M | 2.5M | 964K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 14K | 117K | 288K | 505K | 491K | 388K | 217K |
Operating Expenses | 73.96M | 74.72M | 62.73M | 53.47M | 40.86M | 31.08M | 22.79M | 15.57M | 12.2M | 6.12M | 3.95M | 1.72M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 73.96M | 74.72M | 62.73M | 53.47M | 40.86M | 31.08M | 22.79M | 15.57M | 12.2M | 6.12M | 3.95M | 1.72M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 21.85M | 21.82M | 21.82M | 21.75M | 21.69M | 21.69M | 21.7M | 21.38M | 21.38M | 21.38M | 21.38M | 21.38M |
Shares Outstanding (Diluted) | 21.85M | 21.82M | 21.82M | 21.75M | 21.69M | 21.69M | 21.7M | 21.38M | 21.38M | 21.38M | 21.38M | 21.38M |
EPS (Basic) | -3.21 | -3.21 | -2.65 | -2.24 | -1.69 | -1.28 | -0.95 | -0.65 | -0.54 | -0.29 | -0.19 | -0.10 |
EPS (Diluted) | -3.21 | -3.21 | -2.65 | -2.24 | -1.69 | -1.28 | -0.95 | -0.65 | -0.54 | -0.29 | -0.19 | -0.10 |
EBITDA | -69.86M | -69.83M | -57.56M | -48.75M | -36.61M | -28.27M | -21.14M | -14.4M | -11.7M | -5.69M | -3.51M | -1.48M |
EBIT | -69.89M | -69.87M | -57.59M | -48.77M | -36.64M | -28.33M | -21.2M | -14.48M | -11.8M | -5.74M | -3.56M | -1.5M |
Depreciation & Amortization | 31K | 42K | 36K | 26K | 24K | 61K | 58K | 83K | 101K | 53K | 51K | 26K |
Add to Watchlist
Select watchlists to add or remove AARD